2 hrs ago
Applied Clinical Trials
Sanofi and Regeneron Announce Publication of Positive Phase 2a...
Phase 2a study of the IL-4R alpha inhibitor, dupilumab, demonstrated 87% reduction in risk of asthma exacerbations in moderate-to-severe asthma patients with elevated eosinophils Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine Phase 2a study of the IL-4R alpha ... (more)
It's harder than ever to get a mortgage
BANKS are making it harder to get a mortgage, despite claims they are committed to lending a 3.5bn this year.
Customer Interaction Solutions
Intrinsyc to Report 2013 First Quarter Financial Results
Intrinsyc Software International, Inc. , a leading provider of solutions for the development of embedded and wireless devices, today announced that the Company will release its fiscal first quarter financial results on Wednesday, May 8, 2013 at 4:00 p.m. Eastern Time .
ICS Software Ltd.'s SammyEHR to Now Offer PECOS Lookup for Referring Doctors
ICS Software of New York now offers the ability to automatically check PECOS eligibility of referring doctors through their EHR program, SammyEHR.
Manhattan Dad Proposes International Charter School for Downtown Brooklyn